During the past decade, Carilion Clinic conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 19 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 16 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carilion Clinic" #1 sponsor was "Carilion Clinic" with 15 trials, followed by "Celgene" with 5 trials sponsored, "United Therapeutics" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Tissue Tech Inc." with 4 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carilion Clinic" #1 collaborator was "Virginia Polytechnic Institute and State University" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Carilion Clinic" are "Crohn Disease" (6 trials), "Ulcerative Colitis" (4 trials), "Coronary Artery Disease" (3 trials), "Pulmonary Hypertension" (3 trials) and "Acute Ischemic Stroke" (2 trials). Many other conditions were trialed in "Carilion Clinic" in a lesser frequency.

Most popular intervention types in "Carilion Clinic" are "Drug" (39 trials), "Device" (15 trials), "Other" (10 trials), "Behavioral" (6 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Mirikizumab" (3 trials), "Oral treprostinil" (3 trials), "Ozanimod" (3 trials) and "TTAX01" (3 trials). Other intervention names were less common.

The vast majority of trials in "Carilion Clinic" are 63 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Carilion Clinic". undefined are not yet recruiting, 26 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Carilion Clinic, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Carilion Clinic, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 20 trials that are defined as “Not Applicable".

Carilion Clinic has several departments that took part in Clinical trials: "Carilion Clinic Gynecological Oncology" - 46 trials, "Carilion Children's" - 32 trials, "Institute for Orthopedics and Neurosciences" - 9 trials